Cargando…

Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?

BACKGROUND: Current primary prevention guidelines for cardiovascular disease (CVD) prioritize risk identification, risk stratification using clinical and risk scores, and risk reduction with lifestyle interventions and pharmacotherapy. Subclinical atherosclerosis is an early indicator of atheroscler...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Sarah S., Pilkerton, Courtney S., Shrader, Carl D., Frisbee, Stephanie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880087/ https://www.ncbi.nlm.nih.gov/pubmed/29609588 http://dx.doi.org/10.1186/s12889-018-5263-6

Ejemplares similares

Healthcare resource availability and cardiovascular health in the USA
por: Pilkerton, Courtney S, et al.
Publicado: (2017)

Changes in Cardiovascular Health in the United States, 2003–2011
por: Pilkerton, Courtney S, et al.
Publicado: (2015)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Pharmacological Primary Cardiovascular Prevention and Subclinical Atherosclerosis in Men: Evidence from the Aragon Workers’ Health Study
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2021)

Influence of the Social Environment on Ideal Cardiovascular Health
por: Singh, Sarah S., et al.
Publicado: (2023)

Association of cardiovascular health and risk prediction algorithms with subclinical atherosclerosis identified by carotid ultrasound
por: Azcui Aparicio, Roberto Enrique, et al.
Publicado: (2023)

The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk
por: Li, Yan, et al.
Publicado: (2023)

Association Between a Body Shape Index and Subclinical Carotid Atherosclerosis in Population Free of Cardiovascular and Cerebrovascular Diseases
por: Ma, Xiaotian, et al.
Publicado: (2022)

Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi‐Ethnic Study of Atherosclerosis
por: Polonsky, Tamar S., et al.
Publicado: (2017)

Cardiovascular health and subclinical atherosclerosis in second generation South Asian Americans: The MASALA study
por: Shah, Nilay S., et al.
Publicado: (2021)

The Relationship between Cardiovascular Risk Scores and Several Markers of Subclinical Atherosclerosis in an Asymptomatic Population
por: Mitu, Ovidiu, et al.
Publicado: (2021)

Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study
por: Jia, Yu, et al.
Publicado: (2022)

Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk
por: Gerasimova, Elena V., et al.
Publicado: (2023)

Changes in Cardiovascular Health during Young Adulthood and Subclinical Atherosclerosis in Middle Age: The CARDIA Study
por: Ye, Xiaomin, et al.
Publicado: (2023)

Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
por: Faggiano, Andrea, et al.
Publicado: (2021)

Seronegative immunity to SARS-CoV-2: a case study
por: Miller, Kyle D., et al.
Publicado: (2022)

Association of Childhood Oral Infections With Cardiovascular Risk Factors and Subclinical Atherosclerosis in Adulthood
por: Pussinen, Pirkko J., et al.
Publicado: (2019)

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
por: Gencer, Baris, et al.
Publicado: (2021)

Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index
por: Garoufi, Anastasia, et al.
Publicado: (2021)

Palliative Opioids May Be a Bridge to Care for Rural Long-Term Care Facility Residents with Severe COVID-19 Symptoms
por: Crocetti, Emily, et al.
Publicado: (2021)

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs
por: Kärberg, Kati, et al.
Publicado: (2023)

Secondhand Smoke Exposure and Subclinical Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Jones, Miranda R., et al.
Publicado: (2016)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Full, Kelsie M., et al.
Publicado: (2023)

Analysis of Risk Factors in Patients with Subclinical Atherosclerosis and Increased Cardiovascular Risk Using Factor Analysis
por: Pella, Zuzana, et al.
Publicado: (2021)

Cognition impairment and risk of subclinical cardiovascular disease in older adults: The atherosclerosis risk in communities study
por: Li, Dongze, et al.
Publicado: (2022)

Beneficial Pleiotropic Antidepressive Effects of Cardiovascular Disease Risk Factor Interventions in the Metabolic Syndrome
por: Frisbee, Stephanie J., et al.
Publicado: (2018)

Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations: an H3Africa AWI-Gen study
por: Nonterah, Engelbert A., et al.
Publicado: (2021)

Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events
por: Acquah, Isaac, et al.
Publicado: (2023)

Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records
por: Hivert, Marie-France, et al.
Publicado: (2009)

Subclinical Carotid Atherosclerosis and Reduced DAD Score for Cardiovascular Risk Stratification in HIV-Positive Patients
por: Silva, Achilles Gustavo, et al.
Publicado: (2020)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Impact of Subclinical Atherosclerosis on Cardiovascular Disease Events in Individuals With Metabolic Syndrome and Diabetes: The Multi-Ethnic Study of Atherosclerosis
por: Malik, Shaista, et al.
Publicado: (2011)

Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis
por: Park, Meyeon, et al.
Publicado: (2015)

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2018)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity
por: Ristić, Gorica G., et al.
Publicado: (2015)

Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men
por: Lee, Jung Eun, et al.
Publicado: (2018)

Post-trauma cardiovascular risk factors and subclinical atherosclerosis in young adults following the war in Bosnia and Herzegovina
por: Vulic, Dusko, et al.
Publicado: (2019)

Features of the metabolic syndrome and subclinical atherosclerosis in patients with cerebrotendinous xanthomatosis: An augmented risk for premature cardiovascular disease
por: Cohen, H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3qjlc00d98hh81lplm9ng83nv